Trials / Completed
CompletedNCT02140944
IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence
IMPAACT P1107: Cord Blood Transplantation With CCR5Δ32 Donor Cells in HIV-1 Infected Subjects Who Require Bone Marrow Transplantation for Any Indication and Its Observed Effects on HIV-1 Persistence
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group · Network
- Sex
- All
- Age
- 12 Months
- Healthy volunteers
- Not accepted
Summary
IMPAACT P1107 will describe the outcomes of HIV-infected persons, ages 12 months and older, who undergo transplantation with CCR5Δ32 cord blood stem cells for treatment of cancer, hematopoietic disease, or other underlying disease.
Conditions
Timeline
- Start date
- 2015-02-05
- Primary completion
- 2021-09-30
- Completion
- 2022-10-19
- First posted
- 2014-05-16
- Last updated
- 2023-03-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02140944. Inclusion in this directory is not an endorsement.